| Richard Marc Diamond, MD | |
|
164 Willow Ave, Cornwall, NY 12518-1329 | |
| (845) 534-3888 | |
| (845) 534-4208 |
| Full Name | Richard Marc Diamond |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 47 Years |
| Location | 164 Willow Ave, Cornwall, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316053952 | NPI | - | NPPES |
| 00913855 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 136654 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Cornwall Hospital | Newburgh, NY | Hospital |
| Garnet Health Medical Center | Middletown, NY | Hospital |
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Entity Name | Prestige Physicians Services, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134233497 PECOS PAC ID: 1850384587 Enrollment ID: O20090520000074 |
News Archive
Gov. Paul LePage views the recent Supreme Court health law decision as license to make deep cuts to Maine's Medicaid rolls. Meanwhile, in news related to the Medicaid expansion, Arkansas officials estimate future savings of $372 million if it proceeds with the expansion.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL), in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and the Middle East (excluding Cyprus, Egypt, Israel and Turkey).
"Tonight, President Obama made a forceful case to the Congress and the country for long-overdue health insurance reform. We are closer than ever before in history to real progress on this issue that touches the lives of every American and impacts our economy: ensuring stability and security for Americans with health insurance, and affordable coverage for those currently without.
In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.
Low salt foods are just as safe or safer than high salt level products in spite of expectations that cutting salt levels in food would increase the risk of spoilage by bacteria, say scientists today (Tuesday 4 September 2007) at the Society for General Microbiology¡¦s 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.
› Verified 6 days ago
| Entity Name | Orange Hematology-oncology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841582822 PECOS PAC ID: 1456529551 Enrollment ID: O20110715000177 |
News Archive
Gov. Paul LePage views the recent Supreme Court health law decision as license to make deep cuts to Maine's Medicaid rolls. Meanwhile, in news related to the Medicaid expansion, Arkansas officials estimate future savings of $372 million if it proceeds with the expansion.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL), in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and the Middle East (excluding Cyprus, Egypt, Israel and Turkey).
"Tonight, President Obama made a forceful case to the Congress and the country for long-overdue health insurance reform. We are closer than ever before in history to real progress on this issue that touches the lives of every American and impacts our economy: ensuring stability and security for Americans with health insurance, and affordable coverage for those currently without.
In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.
Low salt foods are just as safe or safer than high salt level products in spite of expectations that cutting salt levels in food would increase the risk of spoilage by bacteria, say scientists today (Tuesday 4 September 2007) at the Society for General Microbiology¡¦s 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Marc Diamond, MD 164 Willow Ave, Cornwall, NY 12518-1329 Ph: (845) 534-3888 | Richard Marc Diamond, MD 164 Willow Ave, Cornwall, NY 12518-1329 Ph: (845) 534-3888 |
News Archive
Gov. Paul LePage views the recent Supreme Court health law decision as license to make deep cuts to Maine's Medicaid rolls. Meanwhile, in news related to the Medicaid expansion, Arkansas officials estimate future savings of $372 million if it proceeds with the expansion.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic leukemia (AML) and acute lymphoblastic leukemia (ALL), in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and the Middle East (excluding Cyprus, Egypt, Israel and Turkey).
"Tonight, President Obama made a forceful case to the Congress and the country for long-overdue health insurance reform. We are closer than ever before in history to real progress on this issue that touches the lives of every American and impacts our economy: ensuring stability and security for Americans with health insurance, and affordable coverage for those currently without.
In a race to market the first vaccine against the virus that causes cervical cancer and genital warts drug manufacturers Merck & Co Inc. and GlaxoSmithKline plc are in head-to-head competition.
Low salt foods are just as safe or safer than high salt level products in spite of expectations that cutting salt levels in food would increase the risk of spoilage by bacteria, say scientists today (Tuesday 4 September 2007) at the Society for General Microbiology¡¦s 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.
› Verified 6 days ago
Philip Sheridan Smith, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 164 Willow Ave, Cornwall, NY 12518 Phone: 845-534-8271 Fax: 845-534-8145 | |
Jonathan Manuel Perez Castro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2570 Route 9w, Cornwall, NY 12518 Phone: 845-651-1400 Fax: 845-651-1512 | |
Eugene Irving Schreiner, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10 Elm St, Cornwall, NY 12518 Phone: 845-534-7818 Fax: 845-534-4171 | |
Susan M Jensen, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2570 Route 9w, Ste 4, Cornwall, NY 12518 Phone: 845-534-1505 Fax: 845-534-1504 | |
Manita Sawhney, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Hudson Vista Medical, Pc, 21 Laurel Avenue, Suite 280, Cornwall, NY 12518 Phone: 845-534-7080 Fax: 845-534-4171 | |
Dr. Nicholas George Bambino, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10 Elm St, Cornwall, NY 12518 Phone: 845-534-7080 Fax: 845-534-4171 |